Danaher Co. (NYSE:DHR) Director John T. Schwieters sold 6,014 shares of Danaher stock in a transaction that occurred on Friday, July 24th. The stock was sold at an average price of $193.95, for a total value of $1,166,415.30. Following the transaction, the director now owns 25,394 shares of the company’s stock, valued at $4,925,166.30. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of NYSE DHR opened at $202.14 on Friday. The stock has a market capitalization of $141.34 billion, a PE ratio of 43.28, a P/E/G ratio of 3.19 and a beta of 0.92. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.20 and a quick ratio of 1.74. The business has a fifty day moving average price of $181.65 and a two-hundred day moving average price of $161.73. Danaher Co. has a fifty-two week low of $119.60 and a fifty-two week high of $204.13.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 23rd. The conglomerate reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.35. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The company had revenue of $5.30 billion during the quarter, compared to analysts’ expectations of $5.01 billion. During the same quarter in the previous year, the firm earned $1.09 EPS. Danaher’s revenue was up 2.7% on a year-over-year basis. On average, equities analysts expect that Danaher Co. will post 5.36 EPS for the current year.
Several institutional investors have recently bought and sold shares of DHR. Lion Street Advisors LLC acquired a new position in shares of Danaher during the 1st quarter worth $25,000. Archer Investment Corp acquired a new position in shares of Danaher during the 4th quarter worth $27,000. Howe & Rusling Inc. raised its holdings in shares of Danaher by 81.4% during the 2nd quarter. Howe & Rusling Inc. now owns 156 shares of the conglomerate’s stock worth $28,000 after buying an additional 70 shares in the last quarter. Manchester Financial Inc. raised its holdings in shares of Danaher by 50.0% during the 1st quarter. Manchester Financial Inc. now owns 228 shares of the conglomerate’s stock worth $32,000 after buying an additional 76 shares in the last quarter. Finally, Semmax Financial Advisors Inc. acquired a new position in shares of Danaher during the 2nd quarter worth $35,000. 77.67% of the stock is owned by institutional investors.
DHR has been the subject of several recent research reports. Bank of America boosted their price target on Danaher from $181.00 to $215.00 and gave the company a “buy” rating in a research note on Monday, July 20th. UBS Group boosted their price target on Danaher from $176.00 to $233.00 and gave the company a “buy” rating in a research note on Monday. Royal Bank of Canada boosted their price target on Danaher from $205.00 to $218.00 and gave the company an “outperform” rating in a research note on Friday, July 24th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $203.00 price target for the company in a research note on Tuesday, July 21st. Finally, Stifel Nicolaus boosted their price target on Danaher from $170.00 to $210.00 and gave the company a “hold” rating in a research note on Friday, July 24th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $197.73.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: How to Use a Moving Average for Trading
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.